Evidence map›Paper›PMID 29305607›Full record

ArticleInvestigative ophthalmology & visual science2018

Novel Insight Into the Role of CFTR in Lacrimal Gland Duct Function in Mice.

Orsolya Berczeli, Eszter Vizvári, Máté Katona, Dénes Török, László Szalay, Ferenc Rárosi, István Németh, Zoltán Rakonczay, Péter Hegyi, Chuanqing Ding and 1 more

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Role of Aquaporin 4 in Lacrimal Gland Ductal Fluid Secretion in Mice.Investigative ophthalmology & visual science · 2024
    Article
  5. Article
  6. Review
  7. Observational
  8. Alpha-Adrenergic Agonists Stimulate Fluid Secretion in Lacrimal Gland Ducts.Investigative ophthalmology & visual science · 2020
    Article
  9. Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry Eye.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2020
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Orsolya BerczeliDepartment of Ophthalmology, University of Szeged, Szeged, Hungary.
Eszter VizváriDepartment of Ophthalmology, University of Szeged, Szeged, Hungary.
Máté Katona1st Department of Internal Medicine, University of Szeged, Szeged, Hungary.
Dénes TörökDepartment of Anatomy, University of Szeged, Szeged, Hungary.
László SzalayDepartment of Ophthalmology, University of Szeged, Szeged, Hungary.
Ferenc RárosiDepartment of Medical Physics and Informatics, University of Szeged, Szeged, Hungary.
István NémethDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
Zoltán Rakonczay1st Department of Internal Medicine, University of Szeged, Szeged, Hungary.
Péter HegyiInstitute for Translational Medicine and First Department of Medicine, University of Pécs, Pécs, Hungary.
Chuanqing DingPharmacology & Pharmaceutical Sciences, Ophthalmology, University of Southern California, Los Angeles, California, United States.
Edit Tóth-MolnárDepartment of Ophthalmology, University of Szeged, Szeged, Hungary.
University of Szeged · HUMTA-SZTE Research Group on Artificial Intelligence · HUUniversity of Southern California · US

Funding

Functional Regulation of the Lacrimal Duct SystemR01EY017731 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI DING, CHUANQING · 2008 to 2011
$1.6M
NEI NIH HHS R01 EY017731
6 · The paper itself

Abstract

Purpose: The role of cystic fibrosis transmembrane conductance regulator (CFTR) in lacrimal gland (LG) function has only recently received some attention, mainly from our group. In the present study, we investigated the potential changes of LG pathology, tear secretion, ocular surface integrity, and fluid secretion in isolated LG ducts from CFTR knockout (KO) mice. Methods: Tear production and ocular surface integrity were investigated in anesthetized wild-type (WT) and KO mice using cotton threads and fluorescein staining, respectively. Immunofluorescence was used to localize CFTR protein in the LGs. Ductal fluid secretions evoked by forskolin (10 μM); cell-permeable cAMP analogue (8-bromo cAMP, 100 μM); or carbachol (100 μM) were measured in isolated LG ducts using video-microscopy. Intracellular Ca2+ homeostasis underlying carbachol stimulation was investigated with microfluorometry. Results: Significant decrease in tear secretion and impaired ocular surface integrity were observed in KO mice. Immunofluorescence demonstrated the predominant presence of CFTR protein in the apical membranes of the duct cells from WT mice. Continuous fluid secretion was evoked by forskolin and 8-bromo cAMP in LG ducts from WT mice, while no secretory response was observed in ducts from KO mice. Carbachol caused similar secretory responses in ducts from WT and KO animals without significant differences in cytosolic Ca2+ signaling. Conclusions: Our results suggest the important role of CFTR in LG ductal secretion and in the maintenance of ocular surface integrity, suggesting that CFTR may be a promising target of novel therapeutic approaches in the treatment of dry eye.

Indexed as

AnimalsBiological TransportCells, CulturedCystic Fibrosis Transmembrane Conductance RegulatorDry Eye SyndromesLacrimal ApparatusMiceMice, Inbred CFTRTearsCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID29305607
PMCPMC5756044
OpenAlexW2782314991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.